Interim CEO Brent Shafer said the medical products maker is ready to begin a new era after several years of “heavy lifting” ...

Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital ...

The Carlyle Group (NASDAQ:CG – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” ...

New York State Teachers Retirement System trimmed its position in The Carlyle Group Inc. (NASDAQ:CG – Free Report) by 0.7% during the 4th quarter, HoldingsChannel reports. The firm owned 44,246 shares ...

The Carlyle Group and SK Capital Partners have agreed to acquire bluebird bio, Inc, a Somerville, Massachusetts-based gene therapy firm, in a take-private deal. According to terms of the agreement, ...

The Carlyle Group has announced the listing of its portfolio company Hexaware Technologies, a global IT services company, on the Bombay Stock Exchange and National Stock Exchange in India. The total ...

Hexaware Technologies shares are showing a muted trend in the grey market. Ahead of the official listing, the company’s ...

Hexaware Technologies Ltd shares debuted with a 5% premium on Wednesday. The IPO was fully subscribed, with Rs 8,750 crore ...

Hexaware Technologies’ stock climbs 10 per cent, lifting expectations; Shares open at ₹745.5 vs IPO price of ₹708 ...

The current Hexaware Technologies IPO GMP indicates a subdued trend. Analysts anticipate a lackluster stock market debut for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...